Category: Abbott LaboratoriesSyndicate content

Indian media accuse Medtronic, Abbott, J&J of price-hikes, bribery

September 16, 2014 by Arezu Sarvestani

Media reports in India claim that some of medtech's biggest companies are looking the other way when their Indian distributors hike prices and bribe doctors to use their drug-eluting stents.

India's news cries price hiking, bribery for Medtronic, Abbott, J&J stents

Some of medtech's biggest players are getting a beating in the Indian media, where reports this week accused them of turning a blind eye to unethical behavior from their distributors in the country.

TCT 2014 Roundup

September 15, 2014 by Brad Perriello

A roundup of studies released at the annual Transcatheter Cardiovascular Therapies conference in Washington this week.

TCT 2014 Roundup

Here's a look at some of the news coming out of Washington at the 26th annual Transcatheter Cardiovascular Therapies conference this week:

Abbott, Medtronic named among world's greenest companies | MassDevice.com On Call

September 12, 2014 by Arezu Sarvestani

The Dow Jones Sustainability World Index names Abbott Labs and Medtronic among the healthcare companies with the most sustainable practices.

MassDevice.com On Call

MASSDEVICE ON CALL — A couple of medtech's biggest players were named among the Dow Jones Sustainability World Index's most environmentally responsible companies.

Abbott (NYSE:ABT) led the sector for the greenest practices, ranked according to "financially material economic, environmental, and social factors."

Abbott puts $60M in Malaysia

September 11, 2014 by Arezu Sarvestani

Abbott Labs pours $60 million into a new manufacturing plant in Malaysia's Kulim Hi-Tech Park.

Abbott puts $60M in Malaysia

Chicago healthcare giant Abbott (NYSE:ABT) is preparing to open a new manufacturing facility and add 500 new employees in Malaysia, according to local reports.

Press Release: Abbott receives CE Mark for FreeStyle Libre, a revolutionary glucose monitoring system for people with diabetes

September 3, 2014 by MassDevice

FreeStyle Libre system eliminates routine finger pricks for glucose measurements and requires no finger pricks for calibration; available for people living with diabetes in several European markets beginning in the coming weeks; advanced ambulatory glucose profile software presents data in a user-friendly, visual chart, enabling productive treatment discussions.

Press Release: Abbott receives CE Mark for Freestyle Libre, a revolutionary glucose monitoring system for people with diabetes

Diabetes: Abbott wins E.U. approval for wearable glucose sensor

September 3, 2014 by Arezu Sarvestani

Abbott lands European CE Mark for its FreeStyle Libre blood glucose meter, a wearable sensor that eliminates the need for routine finger-prick testing.

Diabetes: Abbott wins E.U. approval for prick-free glucose testing

Illinois-based healthcare giant Abbott (NYSE:ABT) is preparing to launch sales of its novel FreeStyle Libre blood glucose sensing system after getting the stamp of approval from European regulators.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Masimo receives warning letter from FDA over its Pronto 7 pulse oximeters | Regulatory news for the week of August 18, 2014

August 19, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Masimo reveals FDA warning letter over Pronto 7 monitor; FDA issues new draft guidance on Class III de novos, UDI for small entities; Medicare finalizes coverage for MitraClip

Masimo reveals FDA warning letter over Pronto 7 monitor

August 15, 2014 by Brad Perriello

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp